Cargando…

Factors associated with coronary heart disease in COPD patients and controls

BACKGROUND: COPD and coronary heart disease (CHD) frequently co-occur, yet which COPD phenotypes are most prone to CHD is poorly understood. The aim of this study was to see whether COPD patients did have a true higher risk for CHD than subjects without COPD, and to examine a range of potential fact...

Descripción completa

Detalles Bibliográficos
Autores principales: Svendsen, Christina D., Kuiper, Karel K. J., Ostridge, Kristoffer, Larsen, Terje H., Nielsen, Rune, Hodneland, Vidar, Nordeide, Eli, Bakke, Per S., Eagan, Tomas M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9045629/
https://www.ncbi.nlm.nih.gov/pubmed/35476713
http://dx.doi.org/10.1371/journal.pone.0265682
_version_ 1784695356692365312
author Svendsen, Christina D.
Kuiper, Karel K. J.
Ostridge, Kristoffer
Larsen, Terje H.
Nielsen, Rune
Hodneland, Vidar
Nordeide, Eli
Bakke, Per S.
Eagan, Tomas M.
author_facet Svendsen, Christina D.
Kuiper, Karel K. J.
Ostridge, Kristoffer
Larsen, Terje H.
Nielsen, Rune
Hodneland, Vidar
Nordeide, Eli
Bakke, Per S.
Eagan, Tomas M.
author_sort Svendsen, Christina D.
collection PubMed
description BACKGROUND: COPD and coronary heart disease (CHD) frequently co-occur, yet which COPD phenotypes are most prone to CHD is poorly understood. The aim of this study was to see whether COPD patients did have a true higher risk for CHD than subjects without COPD, and to examine a range of potential factors associated with CHD in COPD patients and controls. METHODS: 347 COPD patients and 428 non-COPD controls, were invited for coronary computed tomography angiography (CCTA) and pulmonary CT. Arterial blood gas, bioelectrical impedance and lung function was measured, and a detailed medical history taken. The CCTA was evaluated for significant coronary stenosis and calcium score (CaSc), and emphysema defined as >10% of total area <-950 Hounsfield units. RESULTS: 12.6% of the COPD patients and 5.7% of the controls had coronary stenosis (p<0.01), whereas 55.9% of the COPD patients had a CaSc>100 compared to 31.6% of the controls (p<0.01). In a multivariable model adjusting for sex, age, body composition, pack-years, CRP, cholesterol/blood pressure lowering medication use and diabetes mellitus, the OR (95% CI) for having significant stenosis was 1.80 (0.86–3.78) in COPD patients compared with controls. In a similar model, the OR (95% CI) for having CaSc>100 was 1.68 (1.12–2.53) in COPD patients compared with controls. Examining the risk of significant stenosis and CaSc>100 among COPD patients, no variable was associated with significant stenosis, whereas male sex [OR 2.85 (1.56–5.21)], age [OR 3.74 (2.42–5.77)], statin use [OR 2.23 (1.23–4.50)] were associated with CaSc>100, after adjusting for body composition, pack-years, C-reactive protein, use of angiotensin converting enzyme (ACE) inhibitors or angiotensin receptor blockers (ARBs), diabetes, emphysema score, GOLD category, exacerbation frequency, eosinophilia, and hypoxemia. CONCLUSION: COPD patients were more likely to have CHD, but neither emphysema score, lung function, exacerbation frequency, nor hypoxemia predicted presence of either coronary stenosis or CaSc>100.
format Online
Article
Text
id pubmed-9045629
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-90456292022-04-28 Factors associated with coronary heart disease in COPD patients and controls Svendsen, Christina D. Kuiper, Karel K. J. Ostridge, Kristoffer Larsen, Terje H. Nielsen, Rune Hodneland, Vidar Nordeide, Eli Bakke, Per S. Eagan, Tomas M. PLoS One Research Article BACKGROUND: COPD and coronary heart disease (CHD) frequently co-occur, yet which COPD phenotypes are most prone to CHD is poorly understood. The aim of this study was to see whether COPD patients did have a true higher risk for CHD than subjects without COPD, and to examine a range of potential factors associated with CHD in COPD patients and controls. METHODS: 347 COPD patients and 428 non-COPD controls, were invited for coronary computed tomography angiography (CCTA) and pulmonary CT. Arterial blood gas, bioelectrical impedance and lung function was measured, and a detailed medical history taken. The CCTA was evaluated for significant coronary stenosis and calcium score (CaSc), and emphysema defined as >10% of total area <-950 Hounsfield units. RESULTS: 12.6% of the COPD patients and 5.7% of the controls had coronary stenosis (p<0.01), whereas 55.9% of the COPD patients had a CaSc>100 compared to 31.6% of the controls (p<0.01). In a multivariable model adjusting for sex, age, body composition, pack-years, CRP, cholesterol/blood pressure lowering medication use and diabetes mellitus, the OR (95% CI) for having significant stenosis was 1.80 (0.86–3.78) in COPD patients compared with controls. In a similar model, the OR (95% CI) for having CaSc>100 was 1.68 (1.12–2.53) in COPD patients compared with controls. Examining the risk of significant stenosis and CaSc>100 among COPD patients, no variable was associated with significant stenosis, whereas male sex [OR 2.85 (1.56–5.21)], age [OR 3.74 (2.42–5.77)], statin use [OR 2.23 (1.23–4.50)] were associated with CaSc>100, after adjusting for body composition, pack-years, C-reactive protein, use of angiotensin converting enzyme (ACE) inhibitors or angiotensin receptor blockers (ARBs), diabetes, emphysema score, GOLD category, exacerbation frequency, eosinophilia, and hypoxemia. CONCLUSION: COPD patients were more likely to have CHD, but neither emphysema score, lung function, exacerbation frequency, nor hypoxemia predicted presence of either coronary stenosis or CaSc>100. Public Library of Science 2022-04-27 /pmc/articles/PMC9045629/ /pubmed/35476713 http://dx.doi.org/10.1371/journal.pone.0265682 Text en © 2022 Svendsen et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Svendsen, Christina D.
Kuiper, Karel K. J.
Ostridge, Kristoffer
Larsen, Terje H.
Nielsen, Rune
Hodneland, Vidar
Nordeide, Eli
Bakke, Per S.
Eagan, Tomas M.
Factors associated with coronary heart disease in COPD patients and controls
title Factors associated with coronary heart disease in COPD patients and controls
title_full Factors associated with coronary heart disease in COPD patients and controls
title_fullStr Factors associated with coronary heart disease in COPD patients and controls
title_full_unstemmed Factors associated with coronary heart disease in COPD patients and controls
title_short Factors associated with coronary heart disease in COPD patients and controls
title_sort factors associated with coronary heart disease in copd patients and controls
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9045629/
https://www.ncbi.nlm.nih.gov/pubmed/35476713
http://dx.doi.org/10.1371/journal.pone.0265682
work_keys_str_mv AT svendsenchristinad factorsassociatedwithcoronaryheartdiseaseincopdpatientsandcontrols
AT kuiperkarelkj factorsassociatedwithcoronaryheartdiseaseincopdpatientsandcontrols
AT ostridgekristoffer factorsassociatedwithcoronaryheartdiseaseincopdpatientsandcontrols
AT larsenterjeh factorsassociatedwithcoronaryheartdiseaseincopdpatientsandcontrols
AT nielsenrune factorsassociatedwithcoronaryheartdiseaseincopdpatientsandcontrols
AT hodnelandvidar factorsassociatedwithcoronaryheartdiseaseincopdpatientsandcontrols
AT nordeideeli factorsassociatedwithcoronaryheartdiseaseincopdpatientsandcontrols
AT bakkepers factorsassociatedwithcoronaryheartdiseaseincopdpatientsandcontrols
AT eagantomasm factorsassociatedwithcoronaryheartdiseaseincopdpatientsandcontrols